GlassScriptPhysician profile
Kunal P Mehta
NPI 1902115553
$1,879.54
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $281 · 2020: $196 · 2021: $553 · 2022: $459 · 2023: $390.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $331 · Gift: $59.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $330.79 |
| Gift | $59.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $486.61 | 2021-2023 | Aveir, Jot Dx, Assurity |
| Astrazeneca Pharmaceuticals LP | $225.99 | 2020-2023 | Farxiga |
| Cvrx, INC. | $211.07 | 2021 | |
| Boston Scientific Corporation | $167.80 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $155.08 | 2019-2022 | |
| W. L. Gore & Associates, INC. | $115.23 | 2019-2020 | |
| Mannkind Corporation | $59.40 | 2023 | Afrezza |
| Sanofi-Aventis U.S. LLC | $58.18 | 2019-2020 | |
| Medtronic Vascular, INC. | $55.78 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $45.24 | 2021-2022 | |
| Novo Nordisk INC | $44.18 | 2019-2021 | |
| Medtronic, INC. | $41.44 | 2021 | |
| Janssen Pharmaceuticals, INC | $30.54 | 2022 | |
| Amneal Pharmaceuticals LLC | $28.96 | 2019 | |
| Biotronik INC. | $28.78 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cordis US Corp. | $25.78 | 2022 | |
| Chiesi USA, INC. | $22.19 | 2022 | |
| Ibsa Pharma INC. | $20.69 | 2019 | |
| Tandem Diabetes Care, INC. | $19.91 | 2020 | |
| Merck Sharp & Dohme LLC | $14.10 | 2019 | |
| Amarin Pharma, INC. | $11.42 | 2021 | |
| Amgen INC. | $11.17 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kunal Mehta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.